117. Jun J.H., Yoo J.E., Lee J.A. et al. Anemia after gastrectomy in long-term survivors of gastric cancer: A retrospective cohort study. Int J Surg. 2016 Apr;28:162-8. doi: 10.1016/j.ijsu.2016.02.084. www.ncbi.nlm.nih.gov/pubmed/26931339 (дата обращения: 20.01.2021).
118. Andres E., Loukili N.H., Noel E. et al. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ. 2004 Aug 3;171(3):251-9. doi: 10.1503/cmaj.1031155. www. ncbi.nlm.nih.gov/pubmed/15289425 (дата обращения: 20.01.2021).
119. Zhang Y., Hodgson N.W., Trivedi M.S. et al. Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia. PLoS One. 2016 Jan 22;11(1):e0146797. doi: 10.1371/journal.pone.0146797. www.ncbi.nlm.nih.gov/pubmed/26799654 (дата обращения: 20.01.2021).
120. Pascale C.L., Miller M.C., Chiu C. et al. Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent. Fluids Barriers CNS. 2011 Jul 8;8:21. doi: 10.1186/2045-8118-8-21. www.ncbi.nlm.nih.gov/pubmed/21740544 (дата обращения: 20.01.2021).
121. Smith A.D., Smith S.M., de Jager C.A. et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One. 2010 Sep 8;5(9):e12244. doi: 10.1371/journal.pone.0012244. www.ncbi.nlm.nih.gov/pubmed/20838622 (дата обращения: 20.01.2021).
122. Kapoor A., Baig M., Tunio S.A. et al. Neuropsychiatric and neurological problems among Vitamin B12 deficient young vegetarians. Neurosciences (Riyadh). 2017 Jul;22(3):228–232. doi: 10.17712/nsj.2017.3.20160445. www.ncbi.nlm.nih.gov/ pubmed/28678220 (дата обращения: 20.01.2021).
123. Cassano P., Fava M. Depression and public health: an overview. J Psychosom Res. 2002 Oct;53(4):849-57. doi: 10.1016/s0022-3999(02)00304-5. www.ncbi.nlm. nih.gov/pubmed/12377293 (дата обращения: 20.01.2021).
124. Rush A. J. The varied clinical presentations of major depressive disorder. J Clin Psychiatry. 2007;68 Suppl 8:4-10. (Электронный ресурс) URL: www.ncbi.nlm.nih.gov/ pubmed/17640152 (дата обращения: 20.01.2021).
125. Tiemeier H., van Tuijl H.R., Hofman A. et al. Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry. 2002 Dec;159(12):2099-101. doi: 10.1176/appi.ajp.159.12.2099. www.ncbi.nlm.nih.gov/pubmed/12450964 (дата обращения: 20.01.2021).
126. Huang X., Fan Y., Han X. et al. Association between Serum Vitamin Levels and Depression in U.S. Adults 20 Years or Older Based on National Health and Nutrition Examination Survey 2005–2006. Int J Environ Res Public Health. 2018 Jun 9;15(6):1215. doi: 10.3390/ijerph15061215. www.ncbi.nlm.nih.gov/pubmed/29890739 (дата обращения: 20.01.2021).
127. Kunugi H., Hori H., Ogawa S. Biochemical markers subtyping major depressive disorder. Psychiatry Clin Neurosci. 2015 Oct;69(10):597–608. doi: 10.1111/pcn.12299. www.ncbi.nlm.nih.gov/pubmed/25825158 (дата обращения: 20.01.2021).
128. Schaffner A., Li X., Gomez-Llorente Y. et al. Vitamin B 12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection. Cell Res. 2019 Apr;29(4):313–329. doi: 10.1038/s41422-019-0153-8. www.ncbi.nlm. nih.gov/pubmed/30858560 (дата обращения: 20.01.2021).
129. Almeida O.P., Ford A.H., Flicker L. Systematic review and meta-analysis of randomized placebo-controlled trials of folate and vitamin B12 for depression. Int Psychogeriatr. 2015 May;27(5):727-37. doi: 10.1017/S1041610215000046. www.ncbi. nlm.nih.gov/pubmed/25644193 (дата обращения: 20.01.2021).
130. Donaldson M.S. Metabolic vitamin B12 status on a mostly raw vegan diet with follow-up using tablets, nutritional yeast, or probiotic supplements. Ann Nutr Metab. 2000;44(5–6):229-34. doi: 10.1159/000046689. www.ncbi.nlm.nih.gov/ pubmed/11146329 (дата обращения: 20.01.2021).
131. Norman E.J., Morrison J.A. Screening elderly populations for cobalamin (vitamin B12) deficiency using the urinary methylmalonic acid assay by gas chromatography mass spectrometry. Am J Med. 1993 Jun;94(6):589-94. doi: 10.1016/0002-9343(93)90209-8. www.ncbi.nlm.nih.gov/pubmed/8506883 (дата обращения: 21.01.2021).
132. Matchar D.B., McCrory D.C., Millington D.S., Feussner J.R. Performance of the serum cobalamin assay for diagnosis of cobalamin deficiency. Am J Med Sci. 1994 Nov; 308(5):276-83. doi: 10.1097/00000441-199411000-00004. www.ncbi.nlm.nih.gov/ pubmed/7977446 (дата обращения: 21.01.2021).
133. Matchar D.B., Feussner J.R., Millington D.S. et al. Isotope-dilution assay for urinary methylmalonic acid in the diagnosis of vitamin B12 deficiency. A prospective clinical evaluation. Ann Intern Med. 1987 May;106(5):707-10. doi: 10.7326/0003-4819106-5-707. www.ncbi.nlm.nih.gov/pubmed/3551712 (дата обращения: 21.01.2021).
134. Allen R.H., Stabler S.P., Savage D.G., Lindenbaum J. Diagnosis of cobalamin deficiency I: usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol. 1990 Jun;34(2):90-8. doi: 10.1002/ajh.2830340204. www.ncbi.nlm.nih.gov/pubmed/2339683 (дата обращения: 21.01.2021).
135. Moelby L., Rasmussen K., Jensen M.K., Pedersen K.O. The relationship between clinically confirmed cobalamin deficiency and serum methylmalonic acid. J Intern Med. 1990 Oct;228(4):373-8. doi: 10.1111/j.1365–2796.1990.tb00248.x. www.ncbi.nlm.nih. gov/pubmed/2266346 (дата обращения: 21.01.2021).
136. Pennypacker L.C., Allen R.H., Kelly J.P. et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc. 1992 Dec;40(12):1197-204. (Электронный ресурс) URL: www.ncbi.nlm.nih.gov/pubmed/1447433 (дата обращения: 21.01.2021).
137. Tangney C.C., Tang Y., Evans D.A., Morris M.C. Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline. Neurology. 2009 Jan 27;72(4):361-7. doi: 10.1212/01.wnl.0000341272.48617.b0. www.ncbi.nlm.nih.gov/pubmed/19171834 (дата обращения: 21.01.2021).
138. Arendt J.F., Pedersen L., Nexo E., Sorensen H.T. Elevated plasma vitamin B12 levels as a marker for cancer: a population-based cohort study. J Natl Cancer Inst. 2013 Dec 4;105(23):1799-805. doi: 10.1093/jnci/djt315. www.ncbi.nlm.nih.gov/ pubmed/24249744 (дата обращения: 21.01.2021).
139. Arendt J.F., Nexo E. Unexpected high plasma cobalamin: proposal for a diagnostic strategy. Clin Chem Lab Med. 2013 Mar 1;51(3):489-96. doi: 10.1515/cclm-2012-0545. www.ncbi.nlm.nih.gov/pubmed/23241600 (дата обращения: 21.01.2021).
140. Golubkina N.A., Alfthan G.V. The human selenium status in 27 regions of Russia. J Trace Elem Med Biol. 1999 Jul;13(1–2):15–20. doi: 10.1016/S0946-672X(99)80018-2. www.ncbi.nlm.nih.gov/pubmed/10445213 (дата обращения: 21.01.2021).
141. Alehagen U., Aaseth J., Alexander J., Johansson P. Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: A validation of previous 10-year follow-up results of a prospective randomized doubleblind placebo-controlled trial in elderly. PLoS One. 2018 Apr 11;13(4):e0193120. doi: 10.1371/journal.pone.0193120. www.ncbi.nlm.nih.gov/pubmed/29641571 (дата обращения: 21.01.2021).
142. Alehagen U., Johansson P., Bjornstedt M. et al. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens. Int J Cardiol. 2013 Sep 1;167(5):1860-6. doi: 10.1016/j.ijcard.2012.04.156. www.ncbi.nlm.nih.gov/pubmed/22626835 (дата обращения: 21.01.2021).
143. Alehagen U., Aaseth J., Johansson P. Reduced Cardiovascular Mortality 10 Years after Supplementation with Selenium and Coenzyme Q10 for Four Years: FollowUp Results of a Prospective Randomized Double-Blind Placebo-Controlled Trial in Elderly Citizens. PLoS One. 2015 Dec 1;10(12):e0141641. doi: 10.1371/journal.pone.0141641. www.ncbi.nlm.nih.gov/pubmed/26624886 (дата обращения: 21.01.2021).
144. Alehagen U., Aaseth J., Alexander J. et al. Less fibrosis in elderly subjects supplemented with selenium and coenzyme Q10-A mechanism behind reduced cardiovascular mortality? Biofactors. 2018 Mar;44(2):137–147. doi: 10.1002/biof.1404. www.ncbi.nlm.nih.gov/pubmed/29220105 (дата обращения: 21.01.2021).
145. Waters D.J., Chiang E.C. Five threads: How U-shaped thinking weaves together dogs, men, selenium, and prostate cancer risk. Free Radic Biol Med. 2018 Nov 1;127:36–45. doi: 10.1016/j.freeradbiomed.2017.12.039. www.ncbi.nlm.nih.gov/pubmed/29305107 (дата обращения: 21.01.2021).
146. Vinceti M., Vicentini M., Wise L.A et al. Cancer incidence following long-term consumption of drinking water with high inorganic selenium content. Sci Total Environ. 2018 Sep 1;635:390–396. doi: 10.1016/j.scitotenv.2018.04.097. www.ncbi.nlm.nih.gov/ pubmed/29674262 (дата обращения: 21.01.2021).
147. Stranges S., Marshall J.R., Natarajan R. et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 2007 Aug 21;147(4):217-23. doi: 10.7326/0003-4819-147-4-200708210-00175. www.ncbi.nlm.nih.gov/pubmed/17620655 (дата обращения: 21.01.2021).
148. Zhang L., Zeng H., Cheng W.H. Beneficial and paradoxical roles of selenium at nutritional levels of intake in healthspan and longevity. Free Radic Biol Med. 2018 Nov 1;127:3-13. doi: 10.1016/j.freeradbiomed.2018.05.067. www.ncbi.nlm.nih.gov/ pubmed/29782991 (дата обращения: 21.01.2021).
149. Margolis K.L., O’Connor P.J., Morgan T.M. et al. Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial. Diabetes Care. 2014 Jun;37(6):1721-8. doi: 10.2337/dc13-2334. www. ncbi.nlm.nih.gov/pubmed/24595629 (дата обращения: 21.01.2021).
150. Svensson E., Baggesen L.M., Johnsen S.P. et al. Early Glycemic Control and Magnitude of HbA 1c Reduction Predict Cardiovascular Events and Mortality: PopulationBased Cohort Study of 24,752 Metformin Initiators. Diabetes Care. 2017 Jun;40(6):800–807. doi: 10.2337/dc16-2271. www.ncbi.nlm.nih.gov/pubmed/28404659 (дата обращения: 21.01.2021).